Päivi Östling
Päivi Östling
SciLifeLab, Dept. Oncology and Pathology, Karolinska Institutet, FIMM, University of Helsinki
Verified email at ki.se
Cited by
Cited by
Roles of the heat shock transcription factors in regulation of the heat shock response and beyond
L Pirkkala, P Nykänen, LEA Sistonen
The FASEB Journal 15 (7), 1118-1131, 2001
Screening out irrelevant cell-based models of disease
P Horvath, N Aulner, M Bickle, AM Davies, E Del Nery, D Ebner, ...
Nature reviews Drug discovery 15 (11), 751-769, 2016
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells
P Östling, SK Leivonen, A Aakula, P Kohonen, R Mäkelä, Z Hagman, ...
Cancer research 71 (5), 1956-1967, 2011
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
SK Leivonen, R Mäkelä, P Östling, P Kohonen, S Haapa-Paananen, ...
Oncogene 28 (44), 3926-3936, 2009
Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1
P Östling, JK Björk, P Roos-Mattjus, V Mezger, L Sistonen
Journal of Biological Chemistry 282 (10), 7077-7086, 2007
Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKá/IKKâ
S Jin, AP Mutvei, IV Chivukula, ER Andersson, D Ramsköld, R Sandberg, ...
Oncogene 32 (41), 4892-4902, 2013
Role of heat-shock factor 2 in cerebral cortex formation and as a regulatorof p35 expression
Y Chang, P Östling, M Åkerfelt, D Trouillet, M Rallu, Y Gitton, R El Fatimy, ...
Genes & development 20 (7), 836-847, 2006
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion
M Björkman, P Östling, V Härmä, J Virtanen, JP Mpindi, J Rantala, T Mirtti, ...
Oncogene 31 (29), 3444-3456, 2012
Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact
SK Leivonen, A Rokka, P Östling, P Kohonen, GL Corthals, O Kallioniemi, ...
Molecular & Cellular Proteomics 10 (7), M110. 005322, 2011
Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer
K Saeed, V Rahkama, S Eldfors, D Bychkov, JP Mpindi, B Yadav, ...
European urology 71 (3), 319-327, 2017
Systematic identification of microRNAs that impact on proliferation of prostate cancer cells and display changed expression in tumor tissue
A Aakula, P Kohonen, SK Leivonen, R Mäkelä, P Hintsanen, JP Mpindi, ...
European urology 69 (6), 1120-1128, 2016
Accurate morphology preserving segmentation of overlapping cells based on active contours
C Molnar, IH Jermyn, Z Kato, V Rahkama, P Östling, P Mikkonen, ...
Scientific reports 6 (1), 1-10, 2016
Consistency in drug response profiling
JP Mpindi, B Yadav, P Östling, P Gautam, D Malani, A Murumägi, ...
Nature 540 (7631), E5-E6, 2016
MicroRNA-135b regulates ERá, AR and HIF1AN and affects breast and prostate cancer cell growth
A Aakula, SK Leivonen, P Hintsanen, T Aittokallio, Y Ceder, ...
Molecular oncology 9 (7), 1287-1300, 2015
Differentiation lineage‐specific expression of human heat shock transcription factor 2
L Pirkkala, TP Alastalo, P Nykänen, L Seppä, L Sistonen
The FASEB journal 13 (9), 1089-1098, 1999
miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen
O Larne, P Östling, BS Haflidadóttir, Z Hagman, A Aakula, P Kohonen, ...
European urology 68 (4), 581-588, 2015
Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data
JP Mpindi, P Swapnil, B Dmitrii, S Jani, K Saeed, K Wennerberg, ...
Bioinformatics 31 (23), 3815-3821, 2015
Breeze: an integrated quality control and data analysis application for high-throughput drug screening
S Potdar, A Ianevski, JP Mpindi, D Bychkov, C Fiere, P Ianevski, B Yadav, ...
Bioinformatics 36 (11), 3602-3604, 2020
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells
K Saeed, P Ojamies, T Pellinen, S Eldfors, R Turkki, J Lundin, P Järvinen, ...
International journal of cancer 144 (6), 1356-1366, 2019
FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis
SP Turunen, P von Nandelstadh, T Öhman, E Gucciardo, ...
Cell Death & Differentiation 26 (12), 2577-2593, 2019
The system can't perform the operation now. Try again later.
Articles 1–20